A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections

MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 9 vom: 15. Sept., Seite 1387-408
Auteur principal: Suzuki, K (Auteur)
Autres auteurs: Takanashi, K, Naide, Y, Fujita, T, Ogawa, T, Hirabayashi, S, Tamai, H, Yanaoka, M, Ishiguro, K, Asano, H
Format: Article
Langue:Japanese
Publié: 1986
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Journal Article Anti-Bacterial Agents Cyclopropanes Thienamycins Cilastatin 141A6AMN38 Imipenem 71OTZ9ZE0A